ARROWHEAD PHARMACEUTICALS IN (ARWR)
US04280A1007 - Common Stock
ChartMill assigns a Buy % Consensus number of 78% to ARWR. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 48.23. This target is 129.13% above the current price.
ARWR was analyzed by 21 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ARWR.
In the previous month the buy percentage consensus was at a similar level.
ARWR was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-08 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-26 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-09-09 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-09-05 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-12 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2024-07-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-17 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-07-05 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-06-26 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-06-20 | Cantor Fitzgerald | Reiterate | Overweight |
| 2024-06-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-05 | Goldman Sachs | Initiate | Neutral |
| 2024-06-03 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-06-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-13 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-05-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-02-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-02-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-02-07 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-02-07 | Citigroup | Maintains | Neutral -> Neutral |
| 2024-01-16 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-01-02 | B of A Securities | Maintains | Buy -> Buy |
| 2023-12-04 | B of A Securities | Initiate | Buy |
| 2023-11-30 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-11-30 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-19 | Citigroup | Initiate | Neutral |